SCHEMBL9502093

SCHEMBL9502093

CC1CN(c2cc3c(c(NCc4ccccc4)c2F)c(=O)c(C(=O)O)cn3C2CC2)CCN1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.70
HRH3 Q9Y5N1 1/20 0.70
GSK3B P49841 7/20 0.46
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 7/20 0.46
HPGD P15428 5/20 0.46
HSD17B10 Q99714 5/20 0.46
POLB P06746 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
PRKD3 O94806 1/20 0.46
ALOX15 P16050 1/20 0.46
OPRM1 P35372 1/20 0.46
CLK2 P49760 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 3/20 0.45
CYP1A2 P05177 1/20 0.45
TOP2A P11388 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9503714 0.86 KCNH2 (0.51) KCNH2HRH3GSK3BKDM4EALDH1A1
SCHEMBL9501145 0.85 KCNH2 (0.87) KCNH2HRH3GSK3BKDM4EALDH1A1
Grepafloxacin SCHEMBL34157 0.82 KCNH2 (1.00) KCNH2HRH3GSK3BKDM4EALDH1A1
SCHEMBL10774220 0.82 KCNH2 (0.83) KCNH2HRH3GSK3BKDM4EALDH1A1
Grepafloxacin SCHEMBL29695614 0.82 KCNH2 (1.00) KCNH2HRH3GSK3BKDM4EALDH1A1
Grepafloxacin SCHEMBL34156 0.82 KCNH2 (1.00) KCNH2HRH3GSK3BKDM4EALDH1A1
Grepafloxacin SCHEMBL34155 0.82 KCNH2 (1.00) KCNH2HRH3GSK3BKDM4EALDH1A1
Grepafloxacin SCHEMBL1230941 0.82 KCNH2 (0.98) KCNH2HRH3GSK3BKDM4EALDH1A1
Grepafloxacin SCHEMBL29419670 0.82 KCNH2 (0.98) KCNH2HRH3GSK3BKDM4EALDH1A1
SCHEMBL9500988 0.82 KCNH2 (0.81) KCNH2HRH3GSK3BKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0312085-B1 NOVEL QUINOLINE DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND ANTIBACTERIAL AGENT CONTAINING THEM Dainippon Pharmaceutical Co., Ltd. (JP) 1993-05-12 EP disclosed
US-5164392-A Active against streptococci and staphylococci DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1992-11-17 US disclosed
US-5013841-A Oxo quinoline derivatives DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1991-05-07 US disclosed
EP-0312085-A2 Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them Dainippon Pharmaceutical Co., Ltd. (JP) 1989-04-19 EP disclosed